Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling.
about
Calcium mishandling in diastolic dysfunction: mechanisms and potential therapiesRole of troponin I phosphorylation in protein kinase C-mediated enhanced contractile performance of rat myocytesDifferential contribution of troponin I phosphorylation sites to the endothelin-modulated contractile responseDifferential effects of S100 proteins A2 and A6 on cardiac Ca(2+) cycling and contractile performance.Artificial selection for whole animal low intrinsic aerobic capacity co-segregates with hypoxia-induced cardiac pump failure.Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction.Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performanceTargeting calcium cycling proteins in heart failure through gene transfer.pH-responsive titratable inotropic performance of histidine-modified cardiac troponin I.Single amino acid substitutions define isoform-specific effects of troponin I on myofilament Ca2+ and pH sensitivity.Gene therapy in heart failure.Effects of Modified Parvalbumin EF-Hand Motifs on Cardiac Myocyte Contractile Function.Designing heart performance by gene transfer.Interpreting genetic effects through models of cardiac electromechanics.Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action.Enhanced characterization of contractility in cardiomyocytes during early drug safety assessment.Genetic manipulation of calcium-handling proteins in cardiac myocytes. II. Mathematical modeling studies.Genetic manipulation of calcium-handling proteins in cardiac myocytes. I. Experimental studies.Parvalbumin isoforms differentially accelerate cardiac myocyte relaxation kinetics in an animal model of diastolic dysfunction.
P2860
Q27026716-60006F60-AC22-489D-A88D-866CEB6D7821Q28180214-0C146337-9354-44BB-AEAD-353A260CAF95Q28569756-C6707735-FBF0-43AE-9A04-82AB82850869Q30579578-0C97A650-AA57-4D69-B27B-1FE53AC3E1A2Q33476862-AFD94DBD-0795-4C35-8938-3776E3D3B8D2Q34321370-EC72A119-0CB9-4EF0-9440-DD64824AF486Q34327056-7E5C9FD3-173D-4D54-839B-DDE9B11757C0Q35037546-06D62FD1-097B-4CA4-9D70-D56E8DC23FFAQ35866813-5881D658-99E0-44A4-BF62-FE288BA4124AQ36095543-16C55BB0-345A-4077-85A6-08D18B565700Q36944623-874C2456-823D-4F90-ACE6-7AF517DB3377Q37084495-2752FF1C-3EBD-45E4-BF43-D96FE0651793Q37299072-DE41C19E-1139-4834-A7B1-30229B059FC9Q38050130-30BF4A2E-4F46-4A6F-AEC3-31B024B2FD23Q40114591-ECF1A071-D94E-4A99-8DD1-D34C1726213DQ41144260-7B6164CC-9D87-4EE4-8208-8F7DA5D96336Q45032164-0A085812-F630-4FC8-9D44-44888FD5B59DQ45032167-D49E5549-1FB6-4289-8F8B-6F6D70A35F17Q51913315-4E6CA089-3DD0-4757-BBDD-814DC2911294
P2860
Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Optimal range for parvalbumin ...... fer and mathematical modeling.
@ast
Optimal range for parvalbumin ...... fer and mathematical modeling.
@en
Optimal range for parvalbumin ...... fer and mathematical modeling.
@nl
type
label
Optimal range for parvalbumin ...... fer and mathematical modeling.
@ast
Optimal range for parvalbumin ...... fer and mathematical modeling.
@en
Optimal range for parvalbumin ...... fer and mathematical modeling.
@nl
prefLabel
Optimal range for parvalbumin ...... fer and mathematical modeling.
@ast
Optimal range for parvalbumin ...... fer and mathematical modeling.
@en
Optimal range for parvalbumin ...... fer and mathematical modeling.
@nl
P2860
P1433
P1476
Optimal range for parvalbumin ...... fer and mathematical modeling.
@en
P2093
Joseph M Metzger
Pierre Coutu
P2860
P304
P356
10.1016/S0006-3495(02)75599-9
P407
P577
2002-05-01T00:00:00Z